Strikingly, ADAM17 and ERBB1/EGFR are both required to maintain high RAS activity in a KrasG12D mouse model of pancreatic ductal carcinoma (Ardito et al., 2012; Navas et al., 2012). Here, EGFR is linked to pancreatic ductal adenocarcinoma.